Basic Information | Post buying leads | Suppliers |
Name |
Quietalum |
EINECS | N/A |
CAS No. | 545-93-7 | Density | 1.44g/cm3 |
PSA | 82.25000 | LogP | 1.84530 |
Solubility | N/A | Melting Point |
177-179° |
Formula | C10H13 Br N2 O3 | Boiling Point | °Cat760mmHg |
Molecular Weight | 289.129 | Flash Point | °C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, intraperitoneal, and subcutaneous routes. Used as a sedative and hypnotic agent. When heated to decomposition it emits very toxic fumes of NOx and Br−. A controlled drug under 21 CFR 1308.11, which may be habit forming. See also BARBITURATES. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
2,4,6(1H,3H,5H)-Pyrimidinetrione,5-(2-bromo-2-propenyl)-5-(1-methylethyl)- (9CI); Barbituric acid,5-(2-bromoallyl)-5-isopropyl- (8CI); 5-(2-Bromoallyl)-5-isopropylbarbituricacid; 5-(b-Bromoallyl)-5-isopropylbarbituricacid; 5-Isopropyl-5-(2-bromoallyl)barbiturate;5-Isopropyl-5-bromoallylbarbituric acid; Bromoaprobarbital; Ibomal; Kwietal;Noctal; Noctenal; Nostal; Nostral; Propaldon; Propallylonal; Quietal; Quietalum |
IUPAC Name: 5-(2-Bromoprop-2-enyl)-5-propan-2-yl-1,3-diazinane-2,4,6-trione
Synonyms: 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-bromo-2-propen-1-yl)-5-(1-methylethyl)- ; 5-(2-Bromoprop-2-en-1-yl)-5-(propan-2-yl)pyrimidine-2,4,6(1H,3H,5H)-trione ; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-bromo-2-propenyl)-5-(1-methylethyl)- ; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-bromo-2-propenyl)-5-(1-methylethyl)- (9CI)
CAS NO: 545-93-7
Molecular Formula of Quietalum (CAS NO.545-93-7) : C10H13BrN2O3
Molecular Weight of Quietalum (CAS NO.545-93-7) : 289.12582
Molecular Structure of Quietalum (CAS NO.545-93-7) :
EINECS: 208-896-7
Index of Refraction: 1.515
Surface Tension: 40.2 dyne/cm
Density: 1.44 g/cm3
Quietalum (CAS NO.545-93-7) is used as pharmaceutical raw materials.
1. | ipr-rbt LDLo:60 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 44 (1932),325. | ||
2. | scu-rat LD50:90 mg/kg | AEPPAE Naunyn-Schmiedeberg’s Archiv fuer Experimentelle Pathologie und Pharmakologie. 152 (1930),341. | ||
3. | scu-mus LDLo:100 mg/kg | HBAMAK “Abdernalden’s Handbuch der Biologischen Arbeitsmethoden.“ 4 (1935),1289. | ||
4. | orl-rbt LDLo:225 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 44 (1932),325. | ||
5. | ipr-rbt LDLo:120 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 44 (1932),325. | ||
6. | scu-gpg LDLo:80 mg/kg | HBAMAK “Abdernalden’s Handbuch der Biologischen Arbeitsmethoden.“ 4 (1935),1289. | ||
7. | scu-frg LDLo:300 mg/kg | HBAMAK “Abdernalden’s Handbuch der Biologischen Arbeitsmethoden.“ 4 (1935),1289. | ||
8. | orl-mam LDLo:300 mg/kg | JPETAB Journal of Pharmacology and Experimental Therapeutics. 42 (1931),253. |
Poison by ingestion, intraperitoneal, and subcutaneous routes. Used as a sedative and hypnotic agent. When heated to decomposition it emits very toxic fumes of NOx and Br−. A controlled drug under 21 CFR 1308.11, which may be habit forming. See also BARBITURATES.
RIDADR 3249
HazardClass 6.1(b)
PackingGroup III